Partha Sarathi Mukherjee
Research Subjects
Partha Sarathi Mukherjee has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Abhijit Chowdhury
Department of Basic Science and Disease Biology John C. Martin Center for Liver Research and Innovations Kolkata India
3 shared publications - Amal Santra
Centre for Liver Research, School of Digestive & Liver Diseases, Institute of Post Graduate Medical Education & Research, Kolkata, India
3 shared publications - Dipesh Kr Das
Affiliation Liver Foundation, West Bengal, Kolkata, India
3 shared publications - John Joseph Hall
Affiliation School of Population Health, University of New South Wales, Sydney, Australia
3 shared publications - Padmanesan Narasimhan
Affiliation School of Population Health, University of New South Wales, Sydney, Australia
3 shared publications - Poshan Thapa
School of Population and Global Health, McGill University, Montreal, Quebec, Canada
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Hepatology
- Vol. 2026 (1)
Unveiling the Cellular Mystery of Isoniazid–Rifampicin (IR) in CYP2E1 Overexpressing HepG2 Cells
Background and Aims: The molecular basis of liver injury observed following cotreatment with the first‐line antitubercular drugs (ATDs) isoniazid (INH) and rifampicin (RIF) is not fully understood. Cytochrome P450 2E1 (CYP2E1), a key enzyme in drug metabolism, is thought to contribute to INH‐RIF (IR)–associated hepatotoxicity. In this study, we investigated the intracellular events, including lysosomal and mitochondrial alterations, that occur in CYP2E1 overexpressing HepG2 (HepG2‐E47) cells during IR exposure. Methods: HepG2‐E47 cells overexpressing CYP2E1 were cotreated with 5 μ M INH and 2.5 μ M RIF for various time points. Reactive oxygen species (ROS) generation, antioxidant defense status, and CYP2E1 activity were assessed. Lysosomal destabilization, mitochondrial depolarization, and cell death were analyzed using fluorescence spectrophotometer and flow cytometry. To explore CYP2E1 involvement, cells were pretreated with the selective CYP2E1 inhibitor chlormethiazole (CMZ). Pharmacological modulators were used to explore the role of lysosomal and mitochondrial involvement following IR treatment. Results: IR treatment significantly enhanced CYP2E1 activity, ROS production, and impairment of the cellular antioxidant system. These effects were prevented by CMZ, indicating CYP2E1‐dependent oxidative stress. Increased ROS in hepatocytes was accompanied by an early lysosomal dysfunction and cathepsin D release, which were followed by mitochondrial depolarization and apoptosis of the cells. Treatment with bafilomycin, a pharmacological modulator of lysosomal function, alleviated mitochondrial damage, consistent with lysosomal destabilization preceding mitochondrial dysfunction. Conclusion: CYP2E1 plays a pivotal role in IR‐associated cellular injury in CYP2E1 overexpressing HepG2 cells by driving oxidative stress that triggers lysosomal and mitochondrial dysfunction leading to apoptosis. Targeting CYP2E1 or its downstream signalling pathways may provide therapeutic potential against ATD‐associated liver injury.
- 1 January 2026
- Published by Wiley in International Journal of Hepatology
- Vol. 2026 (1)
Open AccessUnveiling the Cellular Mystery of Isoniazid–Rifampicin (IR) in CYP2E1 Overexpressing HepG2 Cells
Background and Aims: The molecular basis of liver injury observed following cotreatment with the first‐line antitubercular drugs (ATDs) isoniazid (INH) and rifampicin (RIF) is not fully understood. Cytochrome P450 2E1 (CYP2E1), a key enzyme in drug metabolism, is thought to contribute to INH‐RIF (IR)–associated hepatotoxicity. In this study, we investigated the intracellular events, including lysosomal and mitochondrial alterations, that occur in CYP2E1 overexpressing HepG2 (HepG2‐E47) cells during IR exposure. Methods: HepG2‐E47 cells overexpressing CYP2E1 were cotreated with 5 μ M INH and 2.5 μ M RIF for various time points. Reactive oxygen species (ROS) generation, antioxidant defense status, and CYP2E1 activity were assessed. Lysosomal destabilization, mitochondrial depolarization, and cell death were analyzed using fluorescence spectrophotometer and flow cytometry. To explore CYP2E1 involvement, cells were pretreated with the selective CYP2E1 inhibitor chlormethiazole (CMZ). Pharmacological modulators were used to explore the role of lysosomal and mitochondrial involvement following IR treatment. Results: IR treatment significantly enhanced CYP2E1 activity, ROS production, and impairment of the cellular antioxidant system. These effects were prevented by CMZ, indicating CYP2E1‐dependent oxidative stress. Increased ROS in hepatocytes was accompanied by an early lysosomal dysfunction and cathepsin D release, which were followed by mitochondrial depolarization and apoptosis of the cells. Treatment with bafilomycin, a pharmacological modulator of lysosomal function, alleviated mitochondrial damage, consistent with lysosomal destabilization preceding mitochondrial dysfunction. Conclusion: CYP2E1 plays a pivotal role in IR‐associated cellular injury in CYP2E1 overexpressing HepG2 cells by driving oxidative stress that triggers lysosomal and mitochondrial dysfunction leading to apoptosis. Targeting CYP2E1 or its downstream signalling pathways may provide therapeutic potential against ATD‐associated liver injury.
- Open Access
- 24 October 2023
- Published by Springer Nature in Research Square
Lean subjects compared to obese with NAFLD have better beta cell function, similar insulin resistance and less fibrosis.
Background: Heterogeneous information on Insulin resistance (IR), adiposity and histological severity in Non-alcoholic Fatty Liver Disease (NAFLD) in lean individuals (NAFLD-L) continues to confound the clinical approach and therapy targets for NAFLD-L, despite its’ growing public health significance, unlike NAFLD in overweight/obese individuals (NAFLD-O). Method: NAFLD-L was evaluated against NAFLD-O in a community cohort (CC) and Tertiary cohort (TC), simultaneously. Leanness was defined as normal BMI with absence of abdominal obesity, using cut-offs for Asians. CC (n=6134), selected from a population project (https://www.shds.co.in/about-birpop/), underwent noninvasive evaluation (HOMA2-IR, Transient Elastography and Dual Energy X-ray Absorptiometry). TC (n=305), selected from two tertiary institutes belonging to the referral hierarchy for the said community, underwent additional evaluation for IR/beta-cell function (BCF) by ‘Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) and histology. Results: NAFLD-L had more android fat than gynoid compared to NAFLD-O [Android to Gynoid Fat mass ratio: median(IQR); 1.38(1.33, 1.39) vs 1.22(1.12, 1.40) in NAFLD-L and NAFLD-O of CC, respectively, p=0.032]. NAFLD-L and NAFLD-O had comparable IR [Median(IQR); 2.47(1.19, 14.80) vs 2.18(1.29, 3.29) mM.mu/l*2 in NAFLD-L and NAFLD-O, respectively, p=0.76] and Non-alcoholic Steatohepatitis (NASH) prevalence. BCF was better in NAFLD-L [Median(IQR); 90.46(59.90, 272) vs 86.63(53.22, 138.15) mu/mM in NAFLD-L and NAFLD-O, respectively, p=0.034]. Cirrhosis was detected only in NAFLD-O. Conclusion: NAFLD-L has IR and NASH prevalence similar to NAFLD-O underscoring uniform pathophysiology and IR as potentially common therapeutic target. Metabolic advantage of having lower prevalence of MS and better BCF is negated by preferential accumulation of more insulin resistant android fat in NAFLD-L.
- 24 October 2023
- Published by Springer Nature in Research Square
Open AccessLean subjects compared to obese with NAFLD have better beta cell function, similar insulin resistance and less fibrosis.
Background: Heterogeneous information on Insulin resistance (IR), adiposity and histological severity in Non-alcoholic Fatty Liver Disease (NAFLD) in lean individuals (NAFLD-L) continues to confound the clinical approach and therapy targets for NAFLD-L, despite its’ growing public health significance, unlike NAFLD in overweight/obese individuals (NAFLD-O). Method: NAFLD-L was evaluated against NAFLD-O in a community cohort (CC) and Tertiary cohort (TC), simultaneously. Leanness was defined as normal BMI with absence of abdominal obesity, using cut-offs for Asians. CC (n=6134), selected from a population project (https://www.shds.co.in/about-birpop/), underwent noninvasive evaluation (HOMA2-IR, Transient Elastography and Dual Energy X-ray Absorptiometry). TC (n=305), selected from two tertiary institutes belonging to the referral hierarchy for the said community, underwent additional evaluation for IR/beta-cell function (BCF) by ‘Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) and histology. Results: NAFLD-L had more android fat than gynoid compared to NAFLD-O [Android to Gynoid Fat mass ratio: median(IQR); 1.38(1.33, 1.39) vs 1.22(1.12, 1.40) in NAFLD-L and NAFLD-O of CC, respectively, p=0.032]. NAFLD-L and NAFLD-O had comparable IR [Median(IQR); 2.47(1.19, 14.80) vs 2.18(1.29, 3.29) mM.mu/l*2 in NAFLD-L and NAFLD-O, respectively, p=0.76] and Non-alcoholic Steatohepatitis (NASH) prevalence. BCF was better in NAFLD-L [Median(IQR); 90.46(59.90, 272) vs 86.63(53.22, 138.15) mu/mM in NAFLD-L and NAFLD-O, respectively, p=0.034]. Cirrhosis was detected only in NAFLD-O. Conclusion: NAFLD-L has IR and NASH prevalence similar to NAFLD-O underscoring uniform pathophysiology and IR as potentially common therapeutic target. Metabolic advantage of having lower prevalence of MS and better BCF is negated by preferential accumulation of more insulin resistant android fat in NAFLD-L.
- Open Access
- 4 October 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (10) , e0001390
Barriers and facilitators to informal healthcare provider engagement in the national tuberculosis elimination program of India: An exploratory study from West Bengal
India has a high burden of Tuberculosis (TB), accounting for a significant portion of global cases. While efforts are being made to engage the formal private sector in the National TB Elimination Program (NTEP) of India, there remains a significant gap in addressing the engagement of Informal Healthcare Providers (IPs), who serve as the first point of contact for healthcare in many communities. Recognizing the increasing evidence of IPs’ importance in TB care, it is crucial to enhance their engagement in the NTEP. Therefore, this study explored various factors influencing the engagement of IPs in the program. A qualitative study was conducted in West Bengal, India, involving 23 IPs and 11 Formal Providers (FPs) from different levels of the formal health system. Thematic analysis of the data was conducted following a six-step approach outlined by Braun and Clarke. Three overarching themes were identified in the analysis, encompassing barriers and facilitators to IPs’ engagement in the NTEP. The first theme focused on IPs’ position and capacity as care providers, highlighting their role as primary care providers and the trust and acceptance extended by the community. The second theme explored policy and system-level drivers and prohibitors, revealing barriers such as role ambiguity, competing tasks, and quality of care issues. Facilitators such as growing recognition of IPs’ importance in the health system, an inclusive incentive system, and willingness to collaborate were also identified. The third theme focused on the relationship between the formal and informal systems, highlighting a need to strengthen the relationship between the two. This study sheds light on factors influencing the engagement of IPs in the NTEP of India. It emphasizes the need for role clarity, knowledge enhancement, and improved relationships between formal and informal systems. By addressing these factors, policymakers and stakeholders can strengthen the engagement of IPs in the NTEP.
- 4 October 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (10) , e0001390
Open AccessBarriers and facilitators to informal healthcare provider engagement in the national tuberculosis elimination program of India: An exploratory study from West Bengal
India has a high burden of Tuberculosis (TB), accounting for a significant portion of global cases. While efforts are being made to engage the formal private sector in the National TB Elimination Program (NTEP) of India, there remains a significant gap in addressing the engagement of Informal Healthcare Providers (IPs), who serve as the first point of contact for healthcare in many communities. Recognizing the increasing evidence of IPs’ importance in TB care, it is crucial to enhance their engagement in the NTEP. Therefore, this study explored various factors influencing the engagement of IPs in the program. A qualitative study was conducted in West Bengal, India, involving 23 IPs and 11 Formal Providers (FPs) from different levels of the formal health system. Thematic analysis of the data was conducted following a six-step approach outlined by Braun and Clarke. Three overarching themes were identified in the analysis, encompassing barriers and facilitators to IPs’ engagement in the NTEP. The first theme focused on IPs’ position and capacity as care providers, highlighting their role as primary care providers and the trust and acceptance extended by the community. The second theme explored policy and system-level drivers and prohibitors, revealing barriers such as role ambiguity, competing tasks, and quality of care issues. Facilitators such as growing recognition of IPs’ importance in the health system, an inclusive incentive system, and willingness to collaborate were also identified. The third theme focused on the relationship between the formal and informal systems, highlighting a need to strengthen the relationship between the two. This study sheds light on factors influencing the engagement of IPs in the NTEP of India. It emphasizes the need for role clarity, knowledge enhancement, and improved relationships between formal and informal systems. By addressing these factors, policymakers and stakeholders can strengthen the engagement of IPs in the NTEP.
- Open Access
- 19 January 2023
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 12, 100142
Stepwise evaluation for the risk of metabolic unhealthiness and significant non-alcoholic fatty liver disease in India
- 19 January 2023
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 12, 100142
Open AccessStepwise evaluation for the risk of metabolic unhealthiness and significant non-alcoholic fatty liver disease in India
- Open Access
- 8 September 2022
- Published by Wiley in International Journal of Hepatology
- Vol. 2022, 1-12
Arsenic-Induced Injury of Mouse Hepatocytes through Lysosome and Mitochondria: An In Vitro Study
Background and Aims. The cellular mechanism of liver injury related to arsenic toxicity is ill defined. It is thought that oxidative stress and mitochondrial dysfunction may play some role in arsenic-induced liver damage. In this study, we evaluated subcellular events within the primary cultured mouse hepatocytes when exposed to inorganic arsenic. Methods. Primary cultured mouse hepatocytes were treated with 10μM arsenic for different time periods. Reactive oxygen species (ROS) formation, functional changes of the lysosome and mitochondria, and mode of hepatocytes death were studied by laser confocal microscopy, fluorescence spectroscopy, and flow cytometry. Expression of proapoptotic member of the BCL-2 family of genes BAX and antiapoptotic BCL-2 mRNA expression were studied by real-time PCR. Cytochrome c expression was studied by Western blotting. Results. Fluorescence spectroscopy as well as flow cytometric analysis revealed that arsenic-induced formation of ROS was time dependent. Confocal microscopy showed initiation of ROS formation from periphery of the hepatocytes at 30min of arsenic exposure that progressed to central part of the hepatocytes at 3h of arsenic exposure. The ROS formation was found to be NADPH oxidase (NOX) dependent. This low level of intracellular ROS induced lysosomal membrane permeabilization (LMP) and subsequently released cathepsin B to the cytosol. The LMP further increased intracellular ROS which in turn triggered induction of mitochondrial permeability transition (MPT). Pretreatment of hepatocytes with LMP inhibitor bafilomycin A (BafA) significantly decreased, and LMP inducer chloroquine (ChQ) significantly increased the production of ROS suggesting that LMP preceded enhanced ROS generation in response to arsenic. MPT was accompanied with increase in BAX:BCL2 mRNA ratio resulting in upregulation of caspase 3 and increased hepatocyte apoptosis. Conclusion. Although arsenic-related oxidative liver injury is well established, neither the site of origin of ROS nor the early sequence of events in arsenic toxicity due to ROS is known. We believe that our study provides evidences elucidating the early sequence of events that culminates in the death of the mouse hepatocytes during arsenic exposure.
- 8 September 2022
- Published by Wiley in International Journal of Hepatology
- Vol. 2022, 1-12
Open AccessArsenic-Induced Injury of Mouse Hepatocytes through Lysosome and Mitochondria: An In Vitro Study
Background and Aims. The cellular mechanism of liver injury related to arsenic toxicity is ill defined. It is thought that oxidative stress and mitochondrial dysfunction may play some role in arsenic-induced liver damage. In this study, we evaluated subcellular events within the primary cultured mouse hepatocytes when exposed to inorganic arsenic. Methods. Primary cultured mouse hepatocytes were treated with 10μM arsenic for different time periods. Reactive oxygen species (ROS) formation, functional changes of the lysosome and mitochondria, and mode of hepatocytes death were studied by laser confocal microscopy, fluorescence spectroscopy, and flow cytometry. Expression of proapoptotic member of the BCL-2 family of genes BAX and antiapoptotic BCL-2 mRNA expression were studied by real-time PCR. Cytochrome c expression was studied by Western blotting. Results. Fluorescence spectroscopy as well as flow cytometric analysis revealed that arsenic-induced formation of ROS was time dependent. Confocal microscopy showed initiation of ROS formation from periphery of the hepatocytes at 30min of arsenic exposure that progressed to central part of the hepatocytes at 3h of arsenic exposure. The ROS formation was found to be NADPH oxidase (NOX) dependent. This low level of intracellular ROS induced lysosomal membrane permeabilization (LMP) and subsequently released cathepsin B to the cytosol. The LMP further increased intracellular ROS which in turn triggered induction of mitochondrial permeability transition (MPT). Pretreatment of hepatocytes with LMP inhibitor bafilomycin A (BafA) significantly decreased, and LMP inducer chloroquine (ChQ) significantly increased the production of ROS suggesting that LMP preceded enhanced ROS generation in response to arsenic. MPT was accompanied with increase in BAX:BCL2 mRNA ratio resulting in upregulation of caspase 3 and increased hepatocyte apoptosis. Conclusion. Although arsenic-related oxidative liver injury is well established, neither the site of origin of ROS nor the early sequence of events in arsenic toxicity due to ROS is known. We believe that our study provides evidences elucidating the early sequence of events that culminates in the death of the mouse hepatocytes during arsenic exposure.
- 3 August 2022
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 37 (9) , 1158-1166
What are the tuberculosis care practices of informal healthcare providers? A cross-sectional study from Eastern India
India is the highest TB burden country, accounting for an estimated 26% of the global TB cases. Systematic engagement of the private sector is a cornerstone of India’s National Strategic Plan for TB Elimination (2017–25). However, informal healthcare providers (IPs), who are the first point of contact for a large number of TB patients, remain significantly underutilized in the National TB Elimination Program of India. Non-prioritization of IPs has also resulted in a limited understanding of their TB care practices in the community. We, therefore, undertook a descriptive study to document IPs’ TB care practices, primarily focusing on their approach to screening, diagnosis, treatment and referral. This cross-sectional study was carried out from February to March 2020 in the Birbhum District of West Bengal, India. Interviews were conducted utilizing the retrospective case study method. A total of 203 IPs participated who reported seeing at least one confirmed TB patient in 6 months prior to the study. In that duration, IPs reported interacting with an average of five suspected TB cases, two of which were later confirmed as having TB. Antibiotic use was found to be common among IPs (highest 69% during the first visit); however, they were prescribed before the patient was suspected or confirmed as having TB. We noted the practice of prolonged treatment among IPs as patients were prescribed medicines until the second follow-up visit. Referral was the preferred TB case management approach among IPs, but delayed referral was observed, with only one-third (34%) of patients being referred to higher health facilities during their first visit. This study presents important findings on IPs’ TB care practices, which have consequences for achieving India’s national goal of TB elimination.
- 3 August 2022
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 37 (9) , 1158-1166
What are the tuberculosis care practices of informal healthcare providers? A cross-sectional study from Eastern India
India is the highest TB burden country, accounting for an estimated 26% of the global TB cases. Systematic engagement of the private sector is a cornerstone of India’s National Strategic Plan for TB Elimination (2017–25). However, informal healthcare providers (IPs), who are the first point of contact for a large number of TB patients, remain significantly underutilized in the National TB Elimination Program of India. Non-prioritization of IPs has also resulted in a limited understanding of their TB care practices in the community. We, therefore, undertook a descriptive study to document IPs’ TB care practices, primarily focusing on their approach to screening, diagnosis, treatment and referral. This cross-sectional study was carried out from February to March 2020 in the Birbhum District of West Bengal, India. Interviews were conducted utilizing the retrospective case study method. A total of 203 IPs participated who reported seeing at least one confirmed TB patient in 6 months prior to the study. In that duration, IPs reported interacting with an average of five suspected TB cases, two of which were later confirmed as having TB. Antibiotic use was found to be common among IPs (highest 69% during the first visit); however, they were prescribed before the patient was suspected or confirmed as having TB. We noted the practice of prolonged treatment among IPs as patients were prescribed medicines until the second follow-up visit. Referral was the preferred TB case management approach among IPs, but delayed referral was observed, with only one-third (34%) of patients being referred to higher health facilities during their first visit. This study presents important findings on IPs’ TB care practices, which have consequences for achieving India’s national goal of TB elimination.
- Open Access
- 30 July 2022
- Published by Oxford University Press (OUP) in International Health
- Vol. 15 (4) , 389-396
Are informal healthcare providers knowledgeable in tuberculosis care? A cross-sectional survey using vignettes in West Bengal, India
Background: India accounts for one-quarter of the world's TB cases. Despite efforts to engage the private sector in India's National TB Elimination Program, informal healthcare providers (IPs), who serve as the first contact for a significant TB patients, remain grossly underutilised. However, considering the substantial evidence establishing IPs' role in patients' care pathway, it is essential to expand the evidence base regarding their knowledge in TB care. Methods: We conducted a cross-sectional study in the Birbhum district of West Bengal, India. The data were collected using the TB vignette among 331 IPs (165 trained and 166 untrained). The correct case management was defined following India's Technical and Operational Guidelines for TB Control. Results: Overall, IPs demonstrated a suboptimal level of knowledge in TB care. IPs exhibited the lowest knowledge in asking essential history questions (all four: 5.4% and at least two: 21.7%) compared with ordering sputum test (76.1%), making a correct diagnosis (83.3%) and appropriate referrals (100%). Nonetheless, a statistically significant difference in knowledge (in most domains of TB care) was observed between trained and untrained IPs. Conclusions: This study identifies gaps in IPs' knowledge in TB care. However, the observed significant difference between the trained and untrained groups indicates a positive impact of training in improving IPs’ knowledge in TB care.
- 30 July 2022
- Published by Oxford University Press (OUP) in International Health
- Vol. 15 (4) , 389-396
Open AccessAre informal healthcare providers knowledgeable in tuberculosis care? A cross-sectional survey using vignettes in West Bengal, India
Background: India accounts for one-quarter of the world's TB cases. Despite efforts to engage the private sector in India's National TB Elimination Program, informal healthcare providers (IPs), who serve as the first contact for a significant TB patients, remain grossly underutilised. However, considering the substantial evidence establishing IPs' role in patients' care pathway, it is essential to expand the evidence base regarding their knowledge in TB care. Methods: We conducted a cross-sectional study in the Birbhum district of West Bengal, India. The data were collected using the TB vignette among 331 IPs (165 trained and 166 untrained). The correct case management was defined following India's Technical and Operational Guidelines for TB Control. Results: Overall, IPs demonstrated a suboptimal level of knowledge in TB care. IPs exhibited the lowest knowledge in asking essential history questions (all four: 5.4% and at least two: 21.7%) compared with ordering sputum test (76.1%), making a correct diagnosis (83.3%) and appropriate referrals (100%). Nonetheless, a statistically significant difference in knowledge (in most domains of TB care) was observed between trained and untrained IPs. Conclusions: This study identifies gaps in IPs' knowledge in TB care. However, the observed significant difference between the trained and untrained groups indicates a positive impact of training in improving IPs’ knowledge in TB care.
- Open Access
Predictors of COVID-19 Vaccine Confidence: Findings from Slums of Four Major Metro Cities of India
There are limited studies on COVID vaccine confidence at the household level in urban slums, which are at high risk of COVID-19 transmission due to overcrowding and poor living conditions. The objective was to understand the reasons influencing COVID-19 vaccine confidence, in terms of barriers and enablers faced by communities in urban slums and informal settlements in four major metro cities in India. A mixed method approach was adopted, where in field studies were conducted during April–May 2021. First, a survey of at least 50 subjects was conducted among residents of informal urban settlements who had not taken any dose of the COVID-19 vaccine in Mumbai, Bengaluru, Kolkata and Delhi; second, a short interview with five subjects who had taken at least one dose of the vaccine in each of the four cities to understand the factors that contributed to positive behaviour and, finally, an in-depth interview of at least 3 key informants in each city to ascertain the vaccination pattern in the communities. The reasons were grouped under contextual, individual/group and vaccine/vaccination specific issues. The most frequent reason (27.7%) was the uncertainty of getting the vaccine. The findings show the need for increasing effectiveness of awareness campaigns, accessibility and the convenience of vaccination, especially among vulnerable groups, to increase the uptake.
Open AccessPredictors of COVID-19 Vaccine Confidence: Findings from Slums of Four Major Metro Cities of India
There are limited studies on COVID vaccine confidence at the household level in urban slums, which are at high risk of COVID-19 transmission due to overcrowding and poor living conditions. The objective was to understand the reasons influencing COVID-19 vaccine confidence, in terms of barriers and enablers faced by communities in urban slums and informal settlements in four major metro cities in India. A mixed method approach was adopted, where in field studies were conducted during April–May 2021. First, a survey of at least 50 subjects was conducted among residents of informal urban settlements who had not taken any dose of the COVID-19 vaccine in Mumbai, Bengaluru, Kolkata and Delhi; second, a short interview with five subjects who had taken at least one dose of the vaccine in each of the four cities to understand the factors that contributed to positive behaviour and, finally, an in-depth interview of at least 3 key informants in each city to ascertain the vaccination pattern in the communities. The reasons were grouped under contextual, individual/group and vaccine/vaccination specific issues. The most frequent reason (27.7%) was the uncertainty of getting the vaccine. The findings show the need for increasing effectiveness of awareness campaigns, accessibility and the convenience of vaccination, especially among vulnerable groups, to increase the uptake.
- 26 May 2020
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 40 (4) , 612-618
A diabetes perception study among rural and urban individuals of West Bengal, India: are we ready for the pandemic?
- 26 May 2020
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 40 (4) , 612-618
A diabetes perception study among rural and urban individuals of West Bengal, India: are we ready for the pandemic?
- Open Access
- 8 August 2016
- Published by Springer Nature in Hepatology, Medicine and Policy
- Vol. 2 (1) , 1-9
Knowledge about hepatitis B and hepatitis C virus infection and consequences: a cross-sectional assessment of baseline knowledge among infected patients in West Bengal, India
India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India limits the potential for prevention and treatment efforts to bring these diseases under control. Since patients’ own knowledge about their health condition may have important health consequences, this study sought to assess knowledge levels among HBV and HCV patients referred to the virology laboratory of the Liver Foundation, West Bengal. Patients who had tested positive for HBsAg or anti-HCV at government specialty clinics were invited to enroll in the study when they presented for follow-up laboratory testing. Study participants completed a survey that contained three multiple-choice questions about viral hepatitis etiology and five multiple-choice questions about the consequences of HBV and HCV infection. Mean knowledge scores for male and female respondents were compared, and comparisons were also made across different places of residence, age groups, education levels and income levels. One-way ANOVA was used to test for significant differences. Among 520 study participants, the mean knowledge score was 4.76 on an eight-point scale. Approximately 40 % of the study sample scored less than 4.0. Almost three-quarters of respondents correctly responded to the question, “Which organ of the human body is affected by hepatitis?” while almost two-thirds knew how hepatitis B is transmitted. Regarding consequences of HBV and HCV infection, less than one-third of study participants answered correctly when asked, “What happens when one is infected with hepatitis B or C?” Slightly more than two-thirds of people correctly answered the question about how hepatitis B is prevented. The mean knowledge score varied across age groups (P = 0.0009), education levels (P = 0.0001) and monthly household income levels (P = 0.0001). With higher levels of schooling and higher household income, there were corresponding increases in knowledge scores. There is room for improving knowledge of HBV and HCV etiology and consequences among patients as well as healthcare workers in India. More awareness activities should be organized, accompanied by further research to track whether knowledge scores improve over time.
- 8 August 2016
- Published by Springer Nature in Hepatology, Medicine and Policy
- Vol. 2 (1) , 1-9
Open AccessKnowledge about hepatitis B and hepatitis C virus infection and consequences: a cross-sectional assessment of baseline knowledge among infected patients in West Bengal, India
India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India limits the potential for prevention and treatment efforts to bring these diseases under control. Since patients’ own knowledge about their health condition may have important health consequences, this study sought to assess knowledge levels among HBV and HCV patients referred to the virology laboratory of the Liver Foundation, West Bengal. Patients who had tested positive for HBsAg or anti-HCV at government specialty clinics were invited to enroll in the study when they presented for follow-up laboratory testing. Study participants completed a survey that contained three multiple-choice questions about viral hepatitis etiology and five multiple-choice questions about the consequences of HBV and HCV infection. Mean knowledge scores for male and female respondents were compared, and comparisons were also made across different places of residence, age groups, education levels and income levels. One-way ANOVA was used to test for significant differences. Among 520 study participants, the mean knowledge score was 4.76 on an eight-point scale. Approximately 40 % of the study sample scored less than 4.0. Almost three-quarters of respondents correctly responded to the question, “Which organ of the human body is affected by hepatitis?” while almost two-thirds knew how hepatitis B is transmitted. Regarding consequences of HBV and HCV infection, less than one-third of study participants answered correctly when asked, “What happens when one is infected with hepatitis B or C?” Slightly more than two-thirds of people correctly answered the question about how hepatitis B is prevented. The mean knowledge score varied across age groups (P = 0.0009), education levels (P = 0.0001) and monthly household income levels (P = 0.0001). With higher levels of schooling and higher household income, there were corresponding increases in knowledge scores. There is room for improving knowledge of HBV and HCV etiology and consequences among patients as well as healthcare workers in India. More awareness activities should be organized, accompanied by further research to track whether knowledge scores improve over time.